SCAR TREATMENT MARKET ANALYSIS

Scar Treatment Market, By Product Type (Topical Scar Product (Gels, Creams, Oils, Sheets), Laser (CO2 Laser, Excimer Laser, Pulsed Dye Laser), Surface Treatment, Injectable), By Scar Type (Atrophic scars (Acne, Trauma and Surgery), Hypertrophic Scars and Keloids, Contractures, Stretch Marks), By End User (Hospitals, Clinics, Pharmacies and Drug Stores, E-Commerce), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Mar 2023
Code : CMI1993
Pages :180
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Scar Treatment Market: Key Developments

On June 12 2022, Syneron Medical Ltd, a cosmetic surgery device manufacturer, acquired Candela Corporation, a laser manufacturing company, under the terms of the merger agreement, Candela shareholders will receive 0.2911 ordinary shares of Syneron for each share of Candela common stock they own. Syneron has issued approximately 6.7 million shares to acquire Candela.

On 28 April 2022, Lumenis Be, Ltd., a global leader in the field of minimally-invasive clinical solutions for the ophthalmology and aesthetic market, announced the launch of triLift, a facial stimulation device targeting three aging elements—structure, contour, and texture—by treating the three tissue layers.

On 17 August 2021, Merz Therapeutics, a manufacturer of pharmaceutical products, came into a partnership with VENSICA, a medical device company for the needleless delivery of botox to treat scars.

On 28 September 2022, Johnson & Johnson Services, a leading healthcare company, announced an independent new consumer health company, Kenvue, which will be a standalone leading global consumer health company in 2023, subject to legal requirements including consultation with works councils and employee representatives, as required.